Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Archives of Internal Medicine

• Publication date

  1993-04-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.1993.00410080037006PMID 8386921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

  2004cited by this paper
• Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.

  1993cited by this paper
• Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.

  1992cited by this paper
• Nifedipine versus fosinopril in uninephrectomized diabetic rats.

  1992cited by this paper
• Angiotensin converting enzyme inhibitors versus calcium antagonists in the treatment of diabetic hypertensive patients.

  1992cited by this paper
• Antihypertensive therapy in a model combining spontaneous hypertension with diabetes.

  1992cited by this paper
• Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria.

  1991cited by this paper
• Renal Hemodynamic Effects of Calcium Antagonists in Rats With Reduced Renal Mass

  1991cited by this paper
• Comparison between perindopril and nifedipine in hypertensive and normotensive diabetic patients with microalbuminuria. Melbourne Diabetic Nephropathy Study Group.

  1991cited by this paper
• The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states.

  1991cited by this paper
• Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.

  1990cited by this paper
• Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.

  1990cited by this paper
• Prevention and treatment of renal disease in insulin-dependent diabetes mellitus.

  1990cited by this paper
• Effects of nifedipine and enalapril on glomerular injury in rats with deoxycorticosterone-salt hypertension.

  1990cited by this paper
• Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.

  1989cited by this paper
• The problem of diabetic renal failure in the United States: an overview.

  1989cited by this paper
• Short and long term effects of antihypertensive therapy in the diabetic rat.

  1989cited by this paper
• Angiotensin-converting enzyme inhibitors in the prevention of experimental diabetic glomerulopathy.

  1989cited by this paper
• Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

  1989cited by this paper
• A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension.

  1989cited by this paper
• Sodium restriction corrects hyperfiltration of diabetes.

  1988cited by this paper
• Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy.

  1988cited by this paper
• Effect of Proteinuria on Mortality in NIDDM

  1988cited by this paper
• "Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy.

  1988cited by this paper
• Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

  1986cited by this paper
• Effects of Long‐term Antihypertensive Treatment on Kidney Function in Diabetic Nephropathy

  1985cited by this paper
• Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes.

  1984cited by this paper
• The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

  1984cited by this paper
• Diabetic Nephropathy and Arterial Hypertension: The Effect of Antihypertensive Treatment

  1983cited by this paper

• THE EFFECT OF CALCIUM CHANNEL Blockers ON moderate or severe ALBUMINURIA IN DIABETIC, HYPERTENSIVE PATIENTS: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.

  2020cites this paper
• Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors

  2020cites this paper
• Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis

  2019cites this paper
• Role of the sodium‐hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes

  2018cites this paper
• 2015 guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the management of hypertension.

  2015cites this paper
• Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: a simulation study.

  2014cites this paper
• Drug Therapy Targets for Diabetic Nephropathy: An Overview

  2013cites this paper
• Term Effects of Diltiazem on Renal Functions : A Controlled Clinical Study

  2012cites this paper
• Predictors of proteinuria reduction by monotherapy with an angiotensin receptor blocker, olmesartan

  2012cites this paper
• Short Term Effects of Diltiazem on Renal Functions: A Controlled Clinical Study Diltiazemin Böbrek İşlevleri Üzerine Kisa Dönem Etkileri: Bir Kontrollü Klinik Çalişma

  2012cites this paper
• Interfaces between medical specialties Thediabetic patient withhypertension

  2011cites this paper
• Prevention and management of chronic kidney disease in type 2 diabetes

  2010cites this paper
• Gender Based Disparities in ACE I/D Polymorphism Associated with Progression of Diabetic Nephropathy in Pakistani Patients with Type 2 Diabetes Mellitus

  2010cites this paper
• Prevention and management of chronic kidney disease in type 2 diabetes

  2010cites this paper
• Current Issues On The Management Of Hypertension

  2008cites this paper
• Eprosartan in the Primary Prevention of Cardiac Allograft Vascular Disease: A Double-Blind Prospectively Randomized Study using Intravascular Ultrasound

  2008cites this paper
• Chapter 31 – Pharmacologic Treatment of Hypertension

  2007cites this paper
• Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes

  2006cites this paper
• ACE-inhibitor use and the long-term risk of renal failure in diabetes.

  2006cites this paper
• Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.

  2005cites this paper
• Proteinuria reduction: Mandatory consideration or option when selecting an antihypertensive agent?

  2005cites this paper
• Calcium Channel Blockers

  2004cites this paper
• Early Blood Pressure Normalization Independent of the Class of Antihypertensive Agent Prevents Augmented Renal Fibronectin and Albuminuria in Experimental Diabetic Nephropathy

  2004cites this paper
• The role of calcium antagonists in chronic kidney disease.

  2004cites this paper
• CALCIUM CHANNEL BLOCKERS IN THE PREVENTION OF END STAGE RENAL DISEASE: A REVIEW

  2004cites this paper
• Differential effects of calcium antagonist subclasses on markers of nephropathy progression.

  2004cites this paper
• Long-term effects of calcium antagonists

  2004cites this paper
• Cost-effective strategies in the prevention of diabetic nephropathy

  2004cites this paper
• Clinical and therapeutic aspects of diabetic nephropathy.

  2003cites this paper
• Managing chronic renal insufficiency--intertwined roles of non-nephrologist and nephrologist.

  2003cites this paper
• Progression of renal failure with anaemia and multiple effects of angiotensin-converting enzyme inhibitor in rats with renal mass reduction.

  2003cites this paper
• Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).

  2003cites this paper
• Use of Angiotensin‐Converting Enzyme Inhibitors in Patients with Heart Failure and Renal Insufficiency: How Concerned Should We Be by the Rise in Serum Creatinine?

  2002cites this paper
• Pharmacologic management of diabetic nephropathy.

  2002cites this paper
• Update Nephrologie¶Renoprotektion durch Antihypertensiva: Teil I

  2002cites this paper
• Review: Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT1-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension

  2002cites this paper
• Why β-blockers are not cardioprotective in elderly patients with hypertension

  2002cites this paper
• Slowing the Progression of Chronic Renal Parenchymal Disease

  2002cites this paper
• [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study].

  2002cites this paper
• Calcium channel blockade in combination with angiotensin-converting enzyme inhibition or angiotensin II (AT(1)-receptor) antagonism in hypertensive diabetics and patients with renal disease and hypertension.

  2002cites this paper
• The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia.

  2002cites this paper
• Role of diltiazem in pregnant women with chronic renal disease

  2002cites this paper
• [Nephrology update. Kidney protection with antihypertensive drugs: I].

  2002cites this paper
• Why beta-blockers are not cardioprotective in elderly patients with hypertension.

  2002cites this paper
• What do international guidelines say about therapy?

  2001cites this paper
• EVIDENCE-BASED TREATMENT OF HYPERTENSION IN PATIENTS WITH TYPE 2 DIABETES

  2001cites this paper
• Antihypertensive Therapie bei Diabetes mellitus

  2001cites this paper
• Antihypertensive therapy: Progression of Renal Injury

  2001cites this paper
• Treatment of Hypertensive Patients with Chronic Renal Insufficiency

  2001cites this paper
• Slowing the Progression of Renal Disease in Diabetic Patients

  2001cites this paper
• Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study

  2001cites this paper
• Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.

  2000cites this paper
• Selecting antihypertensive therapy in the pregnant woman with diabetes mellitus

  2000cites this paper
• Effect of medical therapy on progressive nephropathy: Influence of pregnancy, diabetes and hypertension

  2000cites this paper
• Long-term effects of amlodipine versus fosinopril on microalbuminuria in elderly hypertensive patients with type 2 diabetes mellitus

  2000cites this paper
• Antihypertensive Treatment in NIDDM, with Special Reference to Abnormal Albuminuria

  2000influential citation
• Enfermedad del músculo cardíaco en la diabetes mellitus

  2000cites this paper
• [Cardiomyopathy in diabetes mellitus].

  2000cites this paper
• Management of Hypertension in Patients with Diabetes Mellitus

  2000cites this paper
• Effect of angiotensin II antagonist eprosartan on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans.

  2000cites this paper
• Intrarenal Renin-Angiotensin System in Healthy Humans Effect of Angiotensin II Antagonist Eprosartan on Hyperglycemia-Induced Activation of Print

  2000cites this paper
• Effect of nitrendipine and nisoldipine on renal structure and function in long-term experimental diabetes in rats.

  2000cites this paper
• [Hypertension and renal insufficiency].

  2000cites this paper
• Nephropathie bei Diabetes mellitus Typ 2

  2000cites this paper
• Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview.

  2000cites this paper
• How to use calcium antagonists in hypertension: putting the JNC-VI guidelines into practice. Joint National Committee for the Prevention, Detection, Evaluation and Treatment of High Blood Pressure.

  1999cites this paper
• Lacidipine reduces high blood pressure and the target organ damage induced by high fructose diet in rats.

  1999cites this paper
• Humans Hyperglycemia and Angiotensin-Mediated Control of the Renal Circulation in Healthy

  1999cites this paper
• The paradox of the low-renin state in diabetic nephropathy.

  1999cites this paper
• Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function

  1999cites this paper
• How to Use Calcium Antagonists in Hypertension

  1999cites this paper
• Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.

  1999cites this paper
• Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion.

  1999cites this paper
• Issues of clinical trial design and data interpretations in hypertension

  1999cites this paper
• Antihypertensive agents in diabetic patients: great benefits, special risks.

  1999cites this paper
• Glomerular permeability during ACE inhibition

  1999cites this paper
• Calcium-channel blockers and the progression of renal disease

  1999cites this paper
• [Guidelines for the treatment of arterial hypertension in diabetes mellitus. The consensus recommendations of the German League for the Fight against High Blood Pressure, Inc., the German Diabetes Society and the Society for Nephrology].

  1999cites this paper
• Antiproteinuric efficacy of verapamil in comparison to trandolapril in non-diabetic renal disease.

  1999cites this paper
• Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.

  1999cites this paper
• Antihypertensive drugs and diabetic nephropathy

  1999cites this paper
• [Nephro-protective effect of calcium antagonists].

  1999cites this paper
• The effect of pregnancy on the natural history of diabetic retinopathy and nephropathy.

  1998cites this paper
• Hypertension and chronic renal failure: the use of ACE inhibitors.

  1998cites this paper
• Effects of antihypertensive therapy on progression of diabetic nephropathy.

  1998cites this paper
• Diabetic nephropathy.

  1998cites this paper
• Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.

  1998cites this paper
• Renoprotective differences between perindopril and enalapril in the diabetic hypertensive rat do not reflect glomerular angiotensin-converting enzyme activity.

  1998cites this paper
• A hipertensão no diabete

  1998cites this paper
• Modern antihypertensive treatment and the progression of renal disease.

  1998cites this paper
• Fixed low-dose drug combination for the treatment of hypertension.

  1998cites this paper
• Metabolic Effects of Isradipine In Normotensive NIDDM Patients With Microalbuminuria

  1998cites this paper
• Renal function in noninsulin-dependent diabetes mellitus patients treated with angiotensin-converting enzyme inhibitors and calcium channel blockers.

  1998cites this paper
• Antihypertensive treatment of patients with proteinuric renal diseases: risks or benefits of calcium channel blockers?

  1998cites this paper
• Effects of antihypertensive therapy on progression of diabetic

  1998cites this paper
• Antiproteinuric e Y cacy of verapamil in comparison to trandolapril in non-diabetic renal disease

  1998cites this paper
• Hypertensive patients and diabetes: a high-risk population.

  1998cites this paper
• Differences in Renal Outcomes with ACE Inhibitors in Type 1 and Type 2 Diabetic Patients: Possible Explanations

  1998cites this paper
• Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy.

  1997cites this paper
• The renal consequences of arterial hypertension.

  1997cites this paper